Articles related to CLINICAL STUDY

Technology to the rescue. Employing artificial intelligence (AI) during a colonoscopy could save money and lead to earlier detection of cancer and better health outcomes for patients. AI detection tools also were associated with a cost savings of $57 per patient after lowering discounted costs from $3,400 to $3,343, which persisted in secondary colonoscopy modeling analysis.

People who are fully vaccinated against COVID-19 have a shorter duration of viable viral shedding and a lower secondary attack rate than partially vaccinated or unvaccinated people. Data from this study provides important evidence that despite the possibility of breakthrough infections, COVID-19 vaccinations remain critically useful for controlling the spread of SARS-CoV-2.

In a 7-year study of 171,000 individuals with a mean age of 56 years, these researchers elucidate the hazard ratio for death from CVD or cancer and levels of daily coffee consumption.

The studies described in Acta Neurologica Belgica assess eight patients who developed a new-onset neuromuscular disorder following COVID-19 vaccination. “These various presentations strengthen the association between COVID-19 vaccination and particular GBS phenotypes,” the researchers noted.